HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

human MEDI-524 monoclonal antibody (Numax)

is a MAb derived from palivizumab with enhanced neutralizing activity against RSV
Also Known As:
Numax; MEDI-524 monoclonal antibody, human; motavizumab
Networked: 12 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Losonsky, Genevieve A: 5 articles (12/2015 - 04/2009)
2. Griffin, M Pamela: 3 articles (12/2015 - 08/2011)
3. Jensen, Kathryn M: 3 articles (12/2015 - 08/2011)
4. Harris, Brian S: 3 articles (12/2015 - 08/2011)
5. Motavizumab Study Group: 3 articles (07/2014 - 04/2009)
6. Harris, Brian: 2 articles (01/2010 - 04/2009)
7. Connor, Edward M: 2 articles (01/2010 - 04/2009)
8. Reid, Raymond: 1 article (12/2015)
9. Jafri, Hasan S: 1 article (12/2015)
10. Santosham, Mathuram: 1 article (12/2015)

Related Diseases

1. Respiratory Tract Infections (Respiratory Tract Infection)
2. Infection
3. Lung Diseases (Lung Disease)
4. Respiratory Sounds (Crackle)
5. Pneumonia (Pneumonitis)

Related Drugs and Biologics

1. palivizumab
2. Intravenous Immunoglobulins (IVIG)
3. Ribavirin (Virazole)
4. Immunoglobulins (Immunoglobulin)
5. Antibodies
6. Anti-Inflammatory Agents (Anti-Inflammatories)
7. respiratory syncytial virus immune globulin intravenous

Related Therapies and Procedures

1. Bone Marrow Transplantation (Transplantation, Bone Marrow)